Auxilium Pharma (AUXL) today had its price target increased by Jefferies (JEF) to $30, as the current stock price presents a good buying opportunity based on the positive Peyronie’s data. A buy rating was issued.
Auxilium Pharma (AUXL) today had its price target increased by Jefferies (JEF) to $30, as the current stock price presents a good buying opportunity based on the positive Peyronie’s data. A buy rating was issued.
